BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Biotech Beach

  Arena Pharmaceuticals Presents Preclinical and Early Clinical Development Data for Olorinab at Crohn’s & Colitis Congress

  Arena Pharmaceuticals, Inc. will present preclinical and early clinical development data from its investigative drug candidate olorinab at the Crohn’s & Colitis Congress® in Las Vegas, NV.

  February 7, 2019

   · 

  5 min read
• Business

  Chicago Doctor Reveals Benefits Of Being A Female Physician For The Pros

  She may be five foot three and 110 pounds soaking wet, but Dr. Kathleen Weber of Midwest Orthopaedics at Rush (MOR) can get a 250-pound outfielder and 6' 9" forward to confide in her about their health concerns.

  February 7, 2019

   · 

  1 min read
• Business

  CVD Announces Appointment of New CFO

  CVD Equipment Corporation announced that Thomas McNeill has been appointed as Chief Financial Officer and Secretary, effective March 4, 2019.

  February 7, 2019

   · 

  3 min read
• Business

  Community Healthcare Trust Incorporated Announces Increased Fourth Quarter Dividend payable on March 1, 2019

  Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended December 31, 2018.

  February 7, 2019

   · 

  3 min read
• Pharm Country

  Greene Tweed Receives Silver Boeing Performance Excellence Award

  Greene Tweed announced that it has received a 2017 Boeing Performance Excellence Award.

  February 7, 2019

   · 

  1 min read
• Deals

  Harpoon Therapeutics Announces Pricing of Initial Public Offering on February 8, 2019

  Harpoon Therapeutics, Inc. announced the pricing of its initial public offering of 5,400,000 shares of its common stock at a price to the public of $14.00 per share.

  February 7, 2019

   · 

  2 min read
• Pharm Country

  Neurogene Announces Presentation of Preclinical Data for Gene Therapies to Treat AGU and CMT4J, Two Rare and Devastating Neurodegenerative Disorders

  Researchers present “proof of concept” data in mice at the WORLDSymposiumTM 2019

  February 7, 2019

   · 

  5 min read
• Business

  National Resident Matching Program President and CEO to Retire

  National physician matching organization partners with global search firm to seek a new leader

  February 7, 2019

   · 

  3 min read
• Business

  St. Anthony’s Triathlon Announced as 2019 USAT Regional Championship in Both Olympic-Distance and Paratriathlon Championship

  USA Triathlon selects the 36th annual St. Anthony’s Triathlon as a 2019 regional championship race

  February 7, 2019

   · 

  2 min read
• Deals

  Blueprint Medicines to Present at Upcoming Investor Conferences in February

  Blueprint Medicines Corporation, a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, announced its participation in the following upcoming investor conferences

  February 7, 2019

   · 

  1 min read